Healthcare
CollectionPro Sets New Standard in Out-of-Network Claims and Surprise Billing for U.S. Physicians
CollectionPro Services LLC is revolutionizing the recovery of out-of-network claims and surprise billing for top U.S. physicians, offering legal-grade support and a contingency-based pricing model to ensure fair reimbursements.
Assisted Living Safety Concerns Highlighted by Recent Tragedies
Recent disasters underscore the importance of emergency preparedness in assisted living facilities, as discussed by Frances Fuller, author of 'Helping Yourself Grow Old'.
Creative Biolabs Advances Precision Immunotherapy with Fc Engineering Technology
Creative Biolabs' innovative Fc engineering technology enhances the therapeutic performance of biologics by optimizing immune effector functions, offering new avenues for treating cancers and autoimmune diseases.
New Book Highlights the Diverse and Courageous History of Nursing
Dr. Shelley Burke's latest publication, 'The Unsung Heroes: Nurses', sheds light on the pivotal yet often overlooked contributions of nurses throughout history, especially those from diverse backgrounds, during the COVID-19 pandemic and beyond.
L-UV Revolutionizes Sun Care with Dermatologist-Tested SPF Brand
L-UV is transforming sun safety into a daily lifestyle choice with its dermatologist-tested, sensitive skin-friendly SPF products, emphasizing prevention and style.
Creative Biolabs Enhances Cell Therapy Research with Advanced iPSC and Macrophage Solutions
Creative Biolabs introduces innovative tools and services for iPSC neural differentiation and macrophage isolation, significantly advancing cell therapy research and disease modeling.
NanoViricides' NV-387 Shows Promise as Broad-Spectrum Antiviral with Strategic Pandemic Preparedness Value
NanoViricides, Inc. highlights NV-387's broad antiviral potential and its strategic importance for pandemic preparedness, with plans for a Phase II trial targeting MPox.
Lantern Pharma Reports First Complete Response in Phase 1 LP-284 Trial for Aggressive DLBCL
Lantern Pharma's LP-284 shows promising results in a Phase 1 trial for aggressive DLBCL, marking a significant step forward in the treatment of refractory lymphomas.
CNS Pharmaceuticals Inc. CEO Highlights Company's Vision at Virtual Investor Conference
CNS Pharmaceuticals Inc. CEO John Climaco's participation in the Virtual Investor Summer Spotlight Conference underscores the company's commitment to developing innovative treatments for brain and central nervous system cancers.
Calidi Biotherapeutics Inc. to Showcase RedTail Platform and Oncology Advancements in Investor Webinar
Calidi Biotherapeutics Inc. (NYSE American: CLDI) will host an investor webinar to discuss its RedTail platform and advancements in oncology, highlighting the potential of its CLD-401 candidate to eliminate tumors and activate immune memory.
Experimental mRNA Vaccine Shows Promise in Enhancing Cancer Immunotherapy
Researchers have discovered that an experimental mRNA vaccine could significantly improve the effectiveness of immunotherapy in fighting tumors, marking a potential advancement towards universal cancer vaccines.
K’Alma and Leaf Spas Redefine Wellness with Ancestral and Personalized Approaches During Miami Spa Month
K’Alma and Leaf Spas are distinguishing themselves in Miami Spa Month by blending ancestral healing traditions with personalized wellness treatments, offering unique experiences that cater to both cultural heritage and individual biological needs.
Aditxt Inc. to Showcase Adimune's Innovations in Autoimmune Therapeutics During July 22 Livestream
Aditxt Inc. (NASDAQ: ADTX) will host a livestream to discuss Adimune Inc.'s advancements in autoimmune therapeutics, highlighting the subsidiary's innovative approach and the growing market opportunities.
Quantum BioPharma Ltd. Acquires GameStop Shares in Strategic Move Against Market Manipulation
Quantum BioPharma Ltd. has purchased GameStop shares as part of its campaign against market corruption, highlighting its commitment to combating manipulative trading practices while advancing its biopharmaceutical research.
HeartBeam Inc. Honored with 2025 Innovation Award for Pioneering Remote Cardiac Diagnostics
HeartBeam Inc. (NASDAQ: BEAT) has been awarded the 2025 Innovation Award in Remote Cardiac Diagnostics for its FDA-cleared 3D ECG technology, marking a significant advancement in non-clinical cardiac care.
Limitless Therapy and Wellness Introduces Personalized Physical Therapy Services in Greenville, SC
Limitless Therapy and Wellness launches personalized physical therapy services in Greenville, SC, offering tailored treatment plans to meet individual patient needs for effective recovery and wellness.
New FYZICAL Clinic in Glendale Aims to Revolutionize Fall Prevention and Mobility Care
Melissa Sarhan, an experienced healthcare professional, opens a FYZICAL Therapy & Balance Centers clinic in Glendale, focusing on proactive fall prevention and mobility enhancement to improve patients' quality of life.
Feeding South Florida Launches Hunger Action Month to Combat Food Insecurity
Feeding South Florida initiates Hunger Action Month this September to address the critical issue of food insecurity in the region, offering various ways for the community to contribute and make a difference.
Navigating Health Insurance After Job Loss: A Portland Executive's Journey
Alicia Hunt's experience highlights the challenges and solutions for Oregonians facing health insurance transitions after job loss, emphasizing the importance of seeking guidance.
ReAlta’s Pegtarazimod Demonstrates Potential in Reducing Brain Inflammation in Newborns with HIE
A preclinical study reveals pegtarazimod's ability to significantly reduce brain inflammation in newborns with hypoxic ischemic encephalopathy (HIE), offering hope for a new treatment approach.
Sequel Brands' Marketing Strategy: Building Culturally Resonant Franchises in the Wellness Industry
Nate Chang, Chief Marketing Officer of Sequel Brands, shares insights on creating distinct brand identities within a unified portfolio and the importance of local differentiation in the crowded wellness market.
Emerson Health COO Advocates for Workforce Strategy Overhaul in Healthcare
Eric Stastny, COO of Emerson Health, discusses the urgent need for healthcare systems to adapt workforce strategies to meet the changing expectations of employees, especially Gen Z, to combat high turnover and ensure quality patient care.
DPR Construction's South Florida Leader Highlights Growth and Community Impact
Adrian Barrios of DPR Construction discusses the company's significant role in South Florida's construction sector, emphasizing healthcare projects and community-focused growth.
Dr. Matt Kaeberlein on Bridging the Gap Between Longevity Research and Clinical Practice
Dr. Matt Kaeberlein discusses the transition from academic research to clinical application in longevity science through Optispan, emphasizing evidence-based health optimization.
CLL Society Honors Innovators in Leukemia and Lymphoma Research
The CLL Society has awarded three researchers for their innovative projects aimed at improving care and outcomes for patients with chronic lymphocytic leukemia and small lymphocytic lymphoma, highlighting the importance of integrative medicine, clinical research, and overcoming treatment resistance.
Shoulder Innovations Secures $40 Million in Financing to Advance Shoulder Surgical Care
Shoulder Innovations has closed a $40 million convertible notes financing to further commercialize its advanced implant systems for shoulder arthroplasty, aiming to improve surgical outcomes and efficiency.
Patient Experience 2025 Report Highlights Key Drivers of Trust and Loyalty in Healthcare
The Patient Experience 2025 report by Press Ganey reveals that safety, teamwork, and communication are critical to earning patient trust and loyalty, with data from 10.5 million patient encounters underscoring the importance of reliability and equity in healthcare delivery.
New Machine Learning Model Enhances Cancer Treatment Planning
A collaborative effort between Polish and Brazilian researchers has resulted in a machine learning model that predicts cancer severity, offering a new tool for personalized treatment strategies.
Lantern Pharma Secures EU Patent for AI-Designed Cancer Drug LP-284
Lantern Pharma's EU patent for LP-284, an AI-designed cancer drug, marks a significant step in global commercialization and treatment for non-Hodgkin’s lymphoma.
NanoViricides Announces Promising Results for Measles Treatment in Humanized Animal Study
NanoViricides, Inc. reports a significant breakthrough with its lead drug candidate, NV-387, showing increased survival rates in a lethal measles infection model, highlighting the potential for the first therapeutic option amid rising global measles cases.